Sahajanand Medical Technologies

The Indian government approved applications from Siemens Healthcare, Sahajanand Medical Technologies, Nipro India Corporation, and Wipro GE Healthcare under the PLI scheme for medical devices, with a total committed investment of ₹729.63 crore and expected employment for 2,304 people. Commercial production is projected to start from April 1, 2022.

Sahajanand Medical Technologies (SMT) is setting up Asia's largest stent manufacturing facility in Sultanpur, Sangareddy, with an investment of Rs 250 crore. First stents expected in April or May 2021.

Sahajanand Medical Technologies (SMT) won a national tender from the Italian government to supply up to 40,000 Supraflex Cruz drug-eluting stents by 2022, through its partner Eukon.

Indian medical devices firm Sahajanand Medical Technologies (SMT) acquired a majority stake in Brazil-based Zarek Distribuidora De Produtos Hospitalares for an undisclosed amount through its Irish subsidiary.

Sahajanand Medical Technologies (SMT) will lay the foundation stone for a stent manufacturing unit at the Medical Devices Park in Sultanpur, Sangareddy District, India. The Rs 250 crore facility will have an annual capacity of over 1.25 million stents and create 2200 direct jobs.

Sahajanand Medical Technologies (SMT) announced a new stent manufacturing facility in Hyderabad, India, to be operational by 2020. The investment is INR 2.5 billion (about USD 35 million).

Sahajanand Medical Technologies (SMT) won a tender through its Italian partner Eukon to supply more than 7,000 Supraflex stents to 15 public hospitals in Sicily, Italy over two years starting from 2019.

Sahajanand Medical Technologies (SMT) will set up Asia's largest cardiovascular stent manufacturing plant at Sultanpur Medical Devices park in Sangareddy district, Telangana, with an investment of Rs 250 crore. The plant will create over 2,000 jobs and have a capacity of 1.25 million stents and 2 million balloon catheters per year.

Sahajanand Medical Technologies (SMT), through its Italian partner EUKON S.r.l., signed an agreement with the Emilia Romagna region in Italy to deliver approximately 10,000 Supraflex DES stents over two years.